The in Vitro Ejection of Zinc from Human Immunodeficiency Virus (HIV) Type 1 Nucleocapsid Protein by Disulfide Benzamides with Cellular Anti-HIV Activity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1996 Feb 6

PMID 8577770

Citations 18

Authors

P J Tummino

J D Scholten

P J Harvey

T P Holler

L Maloney

R Gogliotti

J Domagala

D Hupe

Affiliations

Soon will be listed here.

Abstract

Several disulfide benzamides have been shown to possess wide-spectrum antiretroviral activity in cell culture at low micromolar to submicromolar concentrations, inhibiting human immunodeficiency virus (HIV) type 1 (HIV-1) clinical and drug-resistant strains along with HIV-2 and simian immunodeficiency virus [Rice, W. G., Supko, J. G., Malspeis, L., Buckheit, R. W., Jr., Clanton, D., Bu, M., Graham, L., Schaeffer, C. A., Turpin, J. A., Domagala, J., Gogliotti, R., Bader, J. P., Halliday, S. M., Coren, L., Sowder, R. C., II, Arthur, L. O. & Henderson, L. E. (1995) Science 270, 1194-1197]. Rice and coworkers have proposed that the compounds act by "attacking" the two zinc fingers of HIV nucleocapsid protein. Shown here is evidence that low micromolar concentrations of the anti-HIV disulfide benzamides eject zinc from HIV nucleocapsid protein (NCp7) in vitro, as monitored by the zinc-specific fluorescent probe N-(6-methoxy-8-quinoyl)-p-toluenesulfonamide (TSQ). Structurally similar disulfide benzamides that do not inhibit HIV-1 in culture do not eject zinc, nor do analogs of the antiviral compounds with the disulfide replaced with a methylene sulfide. The kinetics of NCp7 zinc ejection by disulfide benzamides were found to be nonsaturable and biexponential, with the rate of ejection from the C-terminal zinc finger 7-fold faster than that from the N-terminal. The antiviral compounds were found to inhibit the zinc-dependent binding of NCp7 to HIV psi RNA, as studied by gel-shift assays, and the data correlated well with the zinc ejection data. Anti-HIV disulfide benzamides specifically eject NCp7 zinc and abolish the protein's ability to bind psi RNA in vitro, providing evidence for a possible antiretroviral mechanism of action of these compounds. Congeners of this class are under advanced preclinical evaluation as a potential chemotherapy for acquired immunodeficiency syndrome.

Citing Articles

The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19.

Prasad A, Malysa A, Bepler G, Fribley A, Bao B Antioxidants (Basel). 2022; 11(10).

PMID: 36290585 PMC: 9598180. DOI: 10.3390/antiox11101862.

NMR Studies of Retroviral Genome Packaging.

Boyd P, Brown J, Brown J, Catazaro J, Chaudry I, Ding P Viruses. 2020; 12(10).

PMID: 33008123 PMC: 7599994. DOI: 10.3390/v12101115.

The potential of putative zinc-binding motifs of haemagglutinin (HA) protein for categorization and prediction of pathogenicity of H5 subtypes of avian influenza virus.

Muraina I, Meseko C, Fasina F Med Hypotheses. 2020; 144:109925.

PMID: 32544740 PMC: 7260503. DOI: 10.1016/j.mehy.2020.109925.

Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.

Mori M, Kovalenko L, Lyonnais S, Antaki D, Torbett B, Botta M Curr Top Microbiol Immunol. 2015; 389:53-92.

PMID: 25749978 PMC: 7122173. DOI: 10.1007/82_2015_433.

Pulse dipolar ESR of doubly labeled mini TAR DNA and its annealing to mini TAR RNA.

Sun Y, Borbat P, Grigoryants V, Myers W, Freed J, Scholes C Biophys J. 2015; 108(4):893-902.

PMID: 25692594 PMC: 4336369. DOI: 10.1016/j.bpj.2014.12.028.

References

Rice W, Schaeffer C, Harten B, Villinger F, South T, Summers M . Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature. 1993; 361(6411):473-5. DOI: 10.1038/361473a0. View

Surovoy A, Waidelich D, Jung G . Nucleocapsid protein of HIV-1 and its Zn2+ complex formation analysis with electrospray mass spectrometry. FEBS Lett. 1992; 311(3):259-62. DOI: 10.1016/0014-5793(92)81115-3. View

Summers M, Henderson L, Chance M, Bess Jr J, South T, Blake P . Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci. 1992; 1(5):563-74. PMC: 2142235. DOI: 10.1002/pro.5560010502. View

Sakaguchi K, Zambrano N, Baldwin E, Shapiro B, Erickson J, Omichinski J . Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc Natl Acad Sci U S A. 1993; 90(11):5219-23. PMC: 46687. DOI: 10.1073/pnas.90.11.5219. View

You J, McHenry C . HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J Biol Chem. 1993; 268(22):16519-27. View

Dorfman T, LUBAN J, Goff S, Haseltine W, Gottlinger H . Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J Virol. 1993; 67(10):6159-69. PMC: 238038. DOI: 10.1128/JVI.67.10.6159-6169.1993. View

Zalewski P, FORBES I, Betts W . Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993; 296 ( Pt 2):403-8. PMC: 1137710. DOI: 10.1042/bj2960403. View

Holler T, Foltin S, Ye Q, Hupe D . HIV1 integrase expressed in Escherichia coli from a synthetic gene. Gene. 1993; 136(1-2):323-8. DOI: 10.1016/0378-1119(93)90488-o. View

Emini E, Byrnes V, Condra J, Schleif W, Sardana V . The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors. Arch Virol Suppl. 1994; 9:11-7. DOI: 10.1007/978-3-7091-9326-6_2. View

10.

Mely Y, Jullian N, Morellet N, de Rocquigny H, Dong C, Piemont E . Spatial proximity of the HIV-1 nucleocapsid protein zinc fingers investigated by time-resolved fluorescence and fluorescence resonance energy transfer. Biochemistry. 1994; 33(40):12085-91. DOI: 10.1021/bi00206a011. View

11.

Coyle P, Zalewski P, Philcox J, FORBES I, Ward A, Lincoln S . Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc. Biochem J. 1994; 303 ( Pt 3):781-6. PMC: 1137615. DOI: 10.1042/bj3030781. View

12.

Otsuka M, Fujita M, Sugiura Y, Ishii S, Tsutomu A, Yamamoto T . Novel zinc chelators which inhibit the binding of HIV-EP1 (HIV enhancer binding protein) to NF-kappa B recognition sequence. J Med Chem. 1994; 37(25):4267-9. DOI: 10.1021/jm00051a002. View

13.

DAquila R, Johnson V, Welles S, Japour A, Kuritzkes D, Degruttola V . Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group. Ann Intern Med. 1995; 122(6):401-8. DOI: 10.7326/0003-4819-122-6-199503150-00001. View

14.

Condra J, Schleif W, Blahy O, Gabryelski L, Graham D, Quintero J . In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995; 374(6522):569-71. DOI: 10.1038/374569a0. View

15.

Larder B, Kemp S, Harrigan P . Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science. 1995; 269(5224):696-9. DOI: 10.1126/science.7542804. View

16.

Rice W, Supko J, Malspeis L, Buckheit Jr R, Clanton D, Bu M . Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science. 1995; 270(5239):1194-7. DOI: 10.1126/science.270.5239.1194. View

17.

Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A . Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. PMC: 253077. DOI: 10.1128/JVI.59.2.284-291.1986. View

18.

Frederickson C, Kasarskis E, Ringo D, Frederickson R . A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J Neurosci Methods. 1987; 20(2):91-103. DOI: 10.1016/0165-0270(87)90042-2. View

19.

Frederickson C, Hernandez M, Goik S, Morton J, McGinty J . Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: a histofluorescence study. Brain Res. 1988; 446(2):383-6. DOI: 10.1016/0006-8993(88)90899-2. View

20.

Green L, Berg J . A retroviral Cys-Xaa2-Cys-Xaa4-His-Xaa4-Cys peptide binds metal ions: spectroscopic studies and a proposed three-dimensional structure. Proc Natl Acad Sci U S A. 1989; 86(11):4047-51. PMC: 287385. DOI: 10.1073/pnas.86.11.4047. View